Skip to main content

Advertisement

Log in

A Prospective, Noninterventional Study of the Treatment of the Aging Hand with Juvéderm Ultra® 3 and Juvéderm® Hydrate

  • Original Article
  • Published:
Aesthetic Plastic Surgery Aims and scope Submit manuscript

Abstract

Background

Hand rejuvenation aims to restore volume and produce smooth, elastic skin. A combined treatment has been proposed: Juvéderm Ultra® 3 for filling and smoothing the skin and Juvéderm® Hydrate to rehydrate and restore skin quality.

Methods

Twenty physicians enrolled 99 subjects (i.e., 198 hands). At the first visit, hands were injected with Juvéderm Ultra® 3. At the second visit (day 15) hands were treated with Juvéderm® Hydrate. A final assessment was made at day 30.

Results

Ninety-eight percent of subjects were female (mean age = 60.3 years). Mean volumes injected were 1.02 ml Juvéderm Ultra® 3 per hand at day 0 and 0.91 ml Juvéderm® Hydrate per hand at day 15. Mean grading on the Hand Aging Scale was 3.18 preinjection, which decreased to 1.73 on study completion (p < 0.0001). Injections were rated as “very easy/easy” in 99.4 and 98.9 % of cases for Juvéderm Ultra® 3 and Juvéderm® Hydrate, respectively. Most physicians found both products “very easy/easy” to massage. Physician evaluation based on the Global Aesthetic Improvement Scale (GAIS) showed that the proportion of “very much/much improved” was significantly higher at days 15 and 30 compared to baseline (63.7 and 70.3 vs. 41.8 %). Patient GAIS scores showed that the proportion of “much improved” was significantly higher at day 30 than at day 15 (53.1 vs. 43.9 %). Over 94 % of physicians and approximately 90 % of subjects would recommend treatment. The adverse event rate was 8.2 %, including edema, hematoma, redness, and pain.

Conclusion

Combined Juvéderm Ultra® 3 and Juvéderm® Hydrate treatment is effective and safe for rejuvenating the aging hand.

Level of Evidence III

This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors at www.springer.com/00266.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Abrams HL, Lauber JS (1990) Hand rejuvenation. The state of the art. Dermatol Clin 8(3):553–561

    PubMed  CAS  Google Scholar 

  2. Shamban AT (2009) Combination hand rejuvenation procedures. Aesthet Surg J 29(5):409–413

    Article  PubMed  Google Scholar 

  3. Carruthers A, Carruthers J, Hardas B, Kaur M, Goertelmeyer R, Jones D, Rzany B, Cohen J, Kerscher M, Flynn TC, Maas C, Sattler G, Gebauer A, Pooth R, McClure K, Simone-Korbel U, Buchner L (2008) A validated hand grading scale. Dermatol Surg 34(Suppl 2):S179–S183

    Article  PubMed  CAS  Google Scholar 

  4. Levy PM, De Boulle K, Raspaldo H (2008) Comparison of injection comfort and ease with Juvéderm ULTRA 3 and Surgiderm 30 XP. Poster presented at International Master Course on Aging Skin (IMCAS), Paris, France, 9–12 January 2008

  5. Smith KC, Melnychuk M (2005) Five percent lidocaine cream applied simultaneously to the skin and mucosa of the lips creates excellent anesthesia for filler injections. Dermatol Surg 31:1635–1637

    Article  PubMed  CAS  Google Scholar 

  6. Shamma AR, Guy RJ (2007) Laser ablation of unwanted hand veins. Plast Reconstr Surg 120(7):2017–2024

    Article  PubMed  CAS  Google Scholar 

  7. Jakubietz R, Grünert JG, Kloss DF, Meffert R, Schmidt K, Jakubietz MG (2009) Aging and the appearance of the hand. Hautarzt 60(3):217, 220-225

    Google Scholar 

Download references

Acknowledgments

The following people were involved in recruiting patients to the study: T. Michaud, Mulhouse, France; I. Rousseaux, Loos, France; L. Fouque Parachini, Nice, France; C. Ligeron, Castelnau Le Lez, France: S. Reynes Van Brabandt, Chateaurenard, France; L. Beille, Grenoble, France; E. Narjoux, Tassin La Demi Lune, France; P. Grolleau-Rochicciolo, Ramonville Saint Agne, France; J. P. Cayatte, Marseille, France; V. Gassia, Toulouse, France; M. Baspeyras, Bordeaux, France; D. Boineau, Bordeaux, France; C Raimbault Gerard, Metz, France; M. Darchy Gilliard, Orleans, France; S. Body, Tours, France; M. Taieb, Paris, France; S. Sebban, Levallois Perret, France; C. de Goursac, Paris, France; M.-H. Charavel Bordeaux, France. Medical writing support for this manuscript was provided by Grey Healthcare.

Disclosures

This study was sponsored by Allergan, Inc. (Irvine, CA, USA) and the author received payment for participation in the study and payments for consultancy services.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jean-Marie Dallara.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dallara, JM. A Prospective, Noninterventional Study of the Treatment of the Aging Hand with Juvéderm Ultra® 3 and Juvéderm® Hydrate. Aesth Plast Surg 36, 949–954 (2012). https://doi.org/10.1007/s00266-012-9890-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00266-012-9890-5

Keywords

Navigation